Tuhina Neogi, MD, PhD

Professor, Medicine

Tuhina Neogi
617.638.5180
650 Albany St Evans Biomed Research Ctr

Biography

I am a rheumatologist and epidemiologist whose research has focused primarily on risk factors for knee osteoarthritis and gout, pain mechanisms in knee osteoarthritis, as well as methodologic issues of relevance for rheumatic diseases. I have had continuous peer-reviewed foundation and NIH funding since 2003, and have over 170 peer-reviewed publications to date. I am the most recent past chair of the FDA Arthritis Advisory Committee, serve on the boards two international societies: Osteoarthritis Research Society International (OARSI) and Gout, Hyperuricemia, and Crystal-Associated Diseases Network (G-CAN), and on committees for the American College of Rheumatology (ACR) and International Association for the Study Pain (IASP), among others. My work has been recognized with the prestigious 2014 ACR Henry Kunkel Young Investigator Award for outstanding and promising independent contributions to rheumatology research (awarded to no more than one clinical researcher and/or one basic science researcher each year). I have also engaged in developing new classification criteria for a number of rheumatic diseases. In addition to research, clinical work, and teaching, one of my key roles is to mentor trainees and junior faculty in musculoskeletal disease-related research. To that end, I was awarded the 2016 Robert Dawson Evans Research Mentoring Award. I am also leading the new CTSI Research Career Support Program initiative, PRIME (Pathways to Research Independence and Mentoring Excellence), which aims to support early career mentored researchers to successfully transition to becoming independent researchers.

Expertise includes:
– Osteoarthritis: epidemiology; risk factors; mechanisms of osteoarthritis-related pain; the role of bone in the pathophysiology of osteoarthritis
– Gout: epidemiology; risk factors and triggers for gout attacks; management of gout; consequences of gout and hyperuricemia
– Classification criteria and outcome measures in rheumatic diseases.
– Novel methodology to address challenging epidemiologic issues

Other Positions

  • Professor, Epidemiology, Boston University School of Public Health
  • Attending Physician, Rheumatology (Arthritis), Medicine, Boston Medical Center

Education

  • University of Toronto, MD
  • Boston University School of Public Health, PhD
  • McMaster University, BS

Classes Taught

Publications

  • Published on 6/13/2018

    Zhang M, Solomon DH, Desai RJ, Kang EH, Liu J, Neogi T, Kim SC. Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study. Circulation. 2018 Jun 13. PMID: 29899013.

    Read at: PubMed
  • Published on 6/8/2018

    Wohlfahrt A, Bingham CO, Marder W, Phillips K, Bolster MB, Moreland LW, Zhang Z, Neogi T, Lee YC. Responsiveness of Patient Reported Outcomes Measurement Information System (PROMIS) Measures in RA Patients Starting or Switching a DMARD. Arthritis Care Res (Hoboken). 2018 Jun 08. PMID: 29885039.

    Read at: PubMed
  • Published on 6/5/2018

    Choi H, Neogi T, Stamp L, Dalbeth N, Terkeltaub R. Implications of the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities (CARES) trial and associated FDA public safety alert. Arthritis Rheumatol. 2018 Jun 05. PMID: 29869840.

    Read at: PubMed
  • Published on 5/2/2018

    Fenton SAM, Neogi T, Dunlop D, Nevitt M, Doherty M, Duda JL, Klocke R, Abhishek A, Rushton A, Zhang W, Lewis CE, Torner J, Kitas G, White DK. Does the intensity of daily walking matter for protecting against the development of a slow gait speed in people with or at high risk of knee osteoarthritis? An observational study. Osteoarthritis Cartilage. 2018 May 02. PMID: 29729332.

    Read at: PubMed
  • Published on 4/19/2018

    Dubreuil M, Louie-Gao Q, Peloquin CE, Choi HK, Zhang Y, Neogi T. Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis. Ann Rheum Dis. 2018 Apr 19. PMID: 29674321.

    Read at: PubMed
  • Published on 4/12/2018

    FitzGerald JD, Mikuls TR, Neogi T, Singh JA, Robbins M, Khanna PP, Turner AS, Myslinski R, Suter LG. Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout. Arthritis Care Res (Hoboken). 2018 May; 70(5):659-671. PMID: 29649348.

    Read at: PubMed
  • Published on 4/2/2018

    Abhishek A, Neogi T, Choi H, Doherty M, Rosenthal AK, Terkeltaub R. Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition. Arthritis Rheumatol. 2018 Apr 02. PMID: 29609209.

    Read at: PubMed
  • Published on 4/2/2018

    Felson DT, Neogi T. Challenges for Osteoarthritis Trials. Arthritis Rheumatol. 2018 Apr 02. PMID: 29609224.

    Read at: PubMed
  • Published on 3/27/2018

    Timilsina S, Brittan K, O'Dell JR, Brophy M, Davis-Karim A, Henrie AM, Neogi T, Newcomb J, Palevsky PM, Pillinger MH, Pittman D, Taylor TH, Wu H, Mikuls TR. Design and Rationale for the Veterans Affairs "Cooperative Study Program 594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat" Trial. Contemp Clin Trials. 2018 May; 68:102-108. PMID: 29597007.

    Read at: PubMed
  • Published on 3/22/2018

    Storey HL, van Pelt MH, Bun S, Daily F, Neogi T, Thompson M, McGuire H, Weigl BH. Diagnostic accuracy of self-administered urine glucose test strips as a diabetes screening tool in a low-resource setting in Cambodia. BMJ Open. 2018 03 22; 8(3):e019924. PMID: 29567849.

    Read at: PubMed

View 179 more publications: View full profile at BUMC

View all profiles